Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Oral immunotherapy for the treatment of peanut allergy: systematic review of six case series studies.

Sheikh A, Nurmatov U, Venderbosch I, Bischoff E.

Prim Care Respir J. 2012 Mar;21(1):41-9. doi: 10.4104/pcrj.2011.00071. Review.

2.

Allergen-specific oral immunotherapy for peanut allergy.

Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009014. doi: 10.1002/14651858.CD009014.pub2. Review.

PMID:
22972130
3.

Successful oral tolerance induction in severe peanut allergy.

Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW.

Allergy. 2009 Aug;64(8):1218-20. doi: 10.1111/j.1398-9995.2009.01982.x. Epub 2009 Feb 17.

4.

Oral peanut immunotherapy in children with peanut anaphylaxis.

Blumchen K, Ulbricht H, Staden U, Dobberstein K, Beschorner J, de Oliveira LC, Shreffler WG, Sampson HA, Niggemann B, Wahn U, Beyer K.

J Allergy Clin Immunol. 2010 Jul;126(1):83-91.e1. doi: 10.1016/j.jaci.2010.04.030. Epub 2010 Jun 12.

PMID:
20542324
5.

Peanut oral immunotherapy: is it ready for clinical practice?

Sampson HA.

J Allergy Clin Immunol Pract. 2013 Jan;1(1):15-21. doi: 10.1016/j.jaip.2012.10.009. Epub 2012 Dec 27. Review.

PMID:
24229817
6.

Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial.

Anagnostou K, Islam S, King Y, Foley L, Pasea L, Bond S, Palmer C, Deighton J, Ewan P, Clark A.

Lancet. 2014 Apr 12;383(9925):1297-304. doi: 10.1016/S0140-6736(13)62301-6. Epub 2014 Jan 30.

7.
8.

Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome.

Anagnostou K, Clark A, King Y, Islam S, Deighton J, Ewan P.

Clin Exp Allergy. 2011 Sep;41(9):1273-81. doi: 10.1111/j.1365-2222.2011.03699.x. Epub 2011 Mar 18.

PMID:
21414048
9.

Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.

Wasserman RL, Factor JM, Baker JW, Mansfield LE, Katz Y, Hague AR, Paul MM, Sugerman RW, Lee JO, Lester MR, Mendelson LM, Nacshon L, Levy MB, Goldberg MR, Elizur A.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):91-6. doi: 10.1016/j.jaip.2013.10.001.

PMID:
24565775
10.

Administration of a probiotic with peanut oral immunotherapy: A randomized trial.

Tang ML, Ponsonby AL, Orsini F, Tey D, Robinson M, Su EL, Licciardi P, Burks W, Donath S.

J Allergy Clin Immunol. 2015 Mar;135(3):737-44.e8. doi: 10.1016/j.jaci.2014.11.034. Epub 2015 Jan 13.

PMID:
25592987
11.

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.

Narisety SD, Frischmeyer-Guerrerio PA, Keet CA, Gorelik M, Schroeder J, Hamilton RG, Wood RA.

J Allergy Clin Immunol. 2015 May;135(5):1275-82.e1-6. doi: 10.1016/j.jaci.2014.11.005. Epub 2014 Dec 18.

12.

Oral immunotherapy for peanut allergy in clinical practice is ready.

Mansfield LE.

Allergy Asthma Proc. 2013 May-Jun;34(3):205-9. doi: 10.2500/aap.2013.34.3666.

PMID:
23676569
13.

Oral and sublingual peanut immunotherapy is not ready for general use.

Greenhawt MJ.

Allergy Asthma Proc. 2013 May-Jun;34(3):197-204. doi: 10.2500/aap.2013.34.3661.

PMID:
23676568
14.

A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.

Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, Hiegel A, Kamilaris J, Carlisle S, Yue X, Kulis M, Pons L, Vickery B, Burks AW.

J Allergy Clin Immunol. 2011 Mar;127(3):654-60. doi: 10.1016/j.jaci.2010.12.1111.

15.

Efficacy of allergen-specific immunotherapy for peanut allergy: a meta-analysis of randomized controlled trials.

Sun J, Hui X, Ying W, Liu D, Wang X.

Allergy Asthma Proc. 2014 Mar-Apr;35(2):171-7. doi: 10.2500/aap.2014.35.3730.

PMID:
24717795
16.

Double-blind placebo-controlled challenge showed that peanut oral immunotherapy was effective for severe allergy without negative effects on airway inflammation.

Kukkonen AK, Uotila R, Malmberg LP, Pelkonen AS, Mäkelä MJ.

Acta Paediatr. 2017 Feb;106(2):274-281. doi: 10.1111/apa.13668.

PMID:
27859599
17.

Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy.

Virkud YV, Burks AW, Steele PH, Edwards LJ, Berglund JP, Jones SM, Scurlock AM, Perry TT, Pesek RD, Vickery BP.

J Allergy Clin Immunol. 2017 Mar;139(3):882-888.e5. doi: 10.1016/j.jaci.2016.07.030. Epub 2016 Sep 5.

PMID:
27609653
18.

Egg oral immunotherapy.

Vickery BP.

Curr Opin Allergy Clin Immunol. 2012 Jun;12(3):278-82. doi: 10.1097/ACI.0b013e3283535bae. Review.

PMID:
22488105
19.

Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial.

Michaud E, Evrard B, Pereira B, Rochette E, Bernard L, Rouzaire PO, Gourdon-Dubois N, Merlin E, Fauquert JL.

Trials. 2015 Apr 29;16:197. doi: 10.1186/s13063-015-0717-y.

20.

Suppression of the immunologic response to peanut during immunotherapy is often transient.

Gorelik M, Narisety SD, Guerrerio AL, Chichester KL, Keet CA, Bieneman AP, Hamilton RG, Wood RA, Schroeder JT, Frischmeyer-Guerrerio PA.

J Allergy Clin Immunol. 2015 May;135(5):1283-92. doi: 10.1016/j.jaci.2014.11.010. Epub 2014 Dec 24.

Supplemental Content

Support Center